Key result
Intensive LDL-C targeting reduces major cardiovascular events vs conventional targets in ASCVD.
CLINICAL IMPACT RATINGS: GIM/FP/GP: [Formula: see text] Cardiology: [Formula: see text].
No takes yet. Share an insight, caveat, or question.
Fuda et al. (2026) studied this question. Intensive LDL-C targeting reduced a composite of cardiovascular events compared to conventional targeting in patients with atherosclerotic cardiovascular disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: